HEARTBEAM, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
HEARTBEAM, INC. (BEAT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 969.66 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-13
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 109.80K shares, a 94.08% decline year-over-year.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 859.86K shares, a 464.21% increase year-over-year.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 135.00K shares, a 92.86% increase year-over-year.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 266.09K shares, a 79.86% decline year-over-year.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 2.41M shares, a 60.10% increase from fiscal 2024.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.50M shares, a 65.51% decline from fiscal 2023.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 4.36M shares, a 248.82% increase from fiscal 2022.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.25M shares, a 84.11% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 109.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 969.66K shares 10-Q · filed 2026-08-13 | 1.10M shares derived: sum of 3 quarters · filed 2026-08-13 | 1.37M shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 859.86K shares 10-Q · filed 2026-05-13 | 994.86K shares derived: sum of 2 quarters · filed 2026-05-13 | 1.26M shares derived: sum of 3 quarters · filed 2026-05-13 | 3.12M shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 135.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 401.09K shares derived: sum of 2 quarters · filed 2026-03-12 | 2.26M shares derived: sum of 3 quarters · filed 2026-03-12 | 2.41M shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 266.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 2.12M shares derived: sum of 2 quarters · filed 2025-11-13 | 2.27M shares 10-Q · filed 2025-11-13 | 2.34M shares derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | 1.86M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 2.01M shares 10-Q · filed 2025-08-13 | 2.08M shares derived: sum of 3 quarters · filed 2026-03-12 | 3.40M shares derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | 152.40K shares 10-Q · filed 2025-05-13 | 222.40K shares derived: sum of 2 quarters · filed 2026-03-12 | 1.54M shares derived: sum of 3 quarters · filed 2026-03-12 | 1.66M shares derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | 70.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 1.39M shares derived: sum of 2 quarters · filed 2026-03-12 | 1.50M shares derived: sum of 3 quarters · filed 2026-03-12 | 1.50M shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 1.32M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 1.44M shares derived: sum of 2 quarters · filed 2024-11-07 | 1.44M shares 10-Q · filed 2024-11-07 | 2.57M shares derived: sum of 4 quarters · filed 2025-03-13 |
| 2024-06-30 | 114.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 114.00K shares 10-Q · filed 2024-08-14 | 1.25M shares derived: sum of 3 quarters · filed 2025-03-13 | 3.36M shares derived: sum of 4 quarters · filed 2025-03-13 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-09 | 1.13M shares derived: sum of 2 quarters · filed 2025-03-13 | 3.25M shares derived: sum of 3 quarters · filed 2025-03-13 | 4.05M shares derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-12-31 | 1.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 3.25M shares derived: sum of 2 quarters · filed 2025-03-13 | 4.05M shares derived: sum of 3 quarters · filed 2025-03-13 | 4.36M shares 10-K · filed 2025-03-13 |
| 2023-09-30 | 2.11M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 2.92M shares derived: sum of 2 quarters · filed 2023-11-14 | 3.23M shares 10-Q · filed 2023-11-14 | 3.35M shares derived: sum of 4 quarters · filed 2024-03-20 |
| 2023-06-30 | 803.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 1.12M shares 10-Q · filed 2023-08-10 | 1.24M shares derived: sum of 3 quarters · filed 2024-03-20 | 1.41M shares derived: sum of 4 quarters · filed 2024-03-20 |
| 2023-03-31 | 312.80K shares 10-Q · filed 2023-05-11 | 432.80K shares derived: sum of 2 quarters · filed 2024-03-20 | 602.80K shares derived: sum of 3 quarters · filed 2024-03-20 | 1.51M shares derived: sum of 4 quarters · filed 2024-03-20 |
| 2022-12-31 | 120.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | 290.00K shares derived: sum of 2 quarters · filed 2024-03-20 | 1.19M shares derived: sum of 3 quarters · filed 2024-03-20 | 1.25M shares 10-K · filed 2024-03-20 |
| 2022-09-30 | 170.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 1.07M shares derived: sum of 2 quarters · filed 2022-11-10 | 1.13M shares 10-Q · filed 2022-11-10 | 1.45M shares derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-06-30 | 903.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 961.00K shares 10-Q · filed 2022-08-11 | 1.28M shares derived: sum of 3 quarters · filed 2023-03-16 | |
| 2022-03-31 | 58.00K shares 10-Q · filed 2022-05-12 | 379.32K shares derived: sum of 2 quarters · filed 2023-03-16 | ||
| 2021-12-31 | 321.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 679.50K shares 10-K · filed 2023-03-16 | ||
| 2021-09-30 | 358.18K shares 10-Q · filed 2021-12-16 | |||
| 2020-12-31 | 214.18K shares 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |